Marimed (MRMD) Non-Current Assets (2013 - 2026)

Marimed (MRMD) has reported Non-Current Assets for 14 consecutive years, with $138.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 5.73% year-over-year to $138.8 million in Q2 2026; TTM through Jun 2026 was $568.0 million, a 6.39% decrease from a year earlier, with the FY2025 full-year figure at $143.3 million, down 6.65% from the prior year.
• Non-Current Assets was $138.8 million for Q2 2026 at Marimed, down from $140.4 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $156.0 million in Q3 2024 and troughed at $82.7 million in Q1 2022.
• A 5-year average of $134.1 million and a median of $141.8 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 62.13% in 2022 and dropped 6.73% in 2025, its largest moves.
• Over 5 years, Non-Current Assets stood at $108.1 million in 2022, then jumped by 33.9% to $144.7 million in 2023, then increased by 6.07% to $153.5 million in 2024, then retreated by 6.65% to $143.3 million in 2025, then declined by 3.12% to $138.8 million in 2026.
• The last three Non-Current Assets figures came in at $138.8 million (Q2 2026), $140.4 million (Q1 2026), and $143.3 million (Q4 2025), per Business Quant data.